Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS25P10 is a processed pseudogene of the ribosomal protein S25 gene, present in the human genome with sequence similarity to RPS25 but lacking the ability to code for a functional protein[6]. Pseudogenes like RPS25P10 originate from gene duplication or retrotransposition events and typically do not contribute to ribosomal function or other cellular processes. The canonical ribosomal protein S25 is a component of the 40S ribosomal subunit involved in protein synthesis, but RPS25P10 itself does not encode an active protein and has not been implicated in human disease or pharmacology[3][4][5][6][7]. For functional analysis or drug targeting, the correct entity is 40S ribosomal protein S25 (RPS25), not the pseudogene RPS25P10.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S25 pseudogene 10 (RPS25P10).